KENDRA BAUGHN: Open Payments
NPI 1487326039 · WHEAT RIDGE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,200 in 60 payments from 21 companies in 2025. Trend: 2023 $334 · 2024 $1,188 · 2025 $1,200
Food & beverage: $1,200
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 9 | $215 |
| Novo Nordisk Inc | 10 | $153 |
| ABBVIE INC. | 5 | $118 |
| Lilly USA, LLC | 6 | $109 |
| PFIZER INC. | 4 | $85 |
| Aimmune Therapeutics, Inc. | 3 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $63 |
| Amgen Inc. | 3 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $45 |
| AstraZeneca Pharmaceuticals LP | 3 | $41 |
Products named: TRELEGY ELLIPTA, MOUNJARO, Wegovy, ZENPEP, VRAYLAR, JARDIANCE, XIFAXAN, ZAVZPRET.
Industry payments across CO — which companies pay providers there.
